1. Home
  2. LION vs NVAX Comparison

LION vs NVAX Comparison

Compare LION & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$9.16

Market Cap

2.4B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.49

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
NVAX
Founded
1997
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
1.6B
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
LION
NVAX
Price
$9.16
$8.49
Analyst Decision
Buy
Hold
Analyst Count
9
9
Target Price
$10.19
$11.33
AVG Volume (30 Days)
2.2M
4.4M
Earning Date
02-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
$3,195,500,000.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.98
N/A
P/E Ratio
N/A
$3.47
Revenue Growth
7.00
64.69
52 Week Low
$5.65
$5.01
52 Week High
$11.02
$11.85

Technical Indicators

Market Signals
Indicator
LION
NVAX
Relative Strength Index (RSI) 45.68 38.12
Support Level $6.46 $8.01
Resistance Level $9.54 $9.05
Average True Range (ATR) 0.39 0.54
MACD -0.08 -0.23
Stochastic Oscillator 3.25 1.81

Price Performance

Historical Comparison
LION
NVAX

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: